
CAS: 2088176-96-7

Ref: 54-BUP08572
25mg | 1,390.00 € | ||
50mg | 1,917.00 € | ||
100mg | 2,533.00 € | ||
500mg | 4,633.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025

3-Bromo-5-(2-Ethylimidazo[1,2-a]pyridine- 3-Carbonyl)-2-Hydroxybenzonitrile
CAS:2088176-96-7
Formula:
C17H12BrN3O2
Molecular weight:
370.21
Ref: 4Z-P-142098
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 13 May 2025

3-Bromo-5-(2-Ethylimidazo[1,2-a]pyridine- 3-Carbonyl)-2-Hydroxybenzonitrile-13C-D4
CAS:2088176-96-7
Formula:
C1613CH8D4BrN3O2
Molecular weight:
375.22
Ref: 4Z-P-142099
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 13 May 2025

Lingdolinurad
CAS:2088176-96-7
Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia …
Formula:
C17H12BrN3O2
Purity:
98.70%
Color and Shape:
Liquid
Molecular weight:
370.2
Ref: TM-T79854
1mg | 185.00 € | ||
5mg | 459.00 € | ||
10mg | 657.00 € | ||
25mg | 1,026.00 € | ||
50mg | 1,415.00 € | ||
100mg | 1,872.00 € | ||
1mL*10mM (DMSO) | 469.00 € |
Estimated delivery in United States, on Tuesday 8 Jul 2025